Patent classifications
C12N2533/74
Preparation Method and Use of Crosslinked Hydrogel for Muscle Stem Cell Culture
The present disclosure discloses a preparation method and use of a crosslinked hydrogel for muscle stem cell culture, and belongs to the technical field of biological food materials. Chitosan, alginate, dextran and Ca.sup.2+ are crosslinked through physical crosslinking to form a double-network hydrogel with a high mechanical strength, the hydrogel is coated with heparin and collagen through dip coating, such that the hydrogel can immobilize growth factors and adhere to cells. Meanwhile, extracted primary muscle stem cells are inoculated onto the hydrogel and cultured in a growth medium (79% of DMEM, 10% of FBS and 1% of double antibodies) for 24 h. The cells are cultured in an incubator with a differential medium (97% of DMEM, 2% of horse serum and 1% of double antibodies) for 7 d. The hydrogel can enhance the absorption to nutrient substances by the muscle stem cells and facilitate growth of the muscle stem cells. The double-network hydrogel has the potential to be a scaffold for growth of muscle stem cells for cultured meat from stem cells.
CULTURE PLATFORMS, METHODS, AND USES THEREOF
The present invention relates to the fields of life sciences and cell and tissue cultures, especially 3D cultures. Specifically, the invention relates to a method of maintaining the presence or activity of a human or mouse estrogen receptor (ER) in a cell of an ex vivo mammary cell or tissue culture or in a cell of other hormone responsive cell or tissue culture. Also, the present invention relates to a method of maintaining a luminal epithelial phenotype and/or cell identity of a mammalian cell in an ex vivo cell or tissue culture. Still, the present invention relates to a 3D matrix or 3D medium comprising the matrix for ex vivo culture, wherein said 3D matrix or 3D medium comprises one or more mammalian cells or tissues embedded in said 3D matrix or 3D medium, and to a system for ex vivo culture, wherein the system comprises mammalian cells or tissues embedded in a 3D matrix or 3D medium comprising said matrix. Still furthermore, the present invention relates to use of the 3D matrix, 3D medium or system of the present invention e.g. for ex vivo culture of a mammalian cell, drug discovery methods, biomarker studies and/or estrogen receptor (ER) signaling studies.
ENHANCED VIRAL TRANSDUCTION OF MAMMALIAN CELLS USING MATERIAL SCAFFOLDS
Disclosed are compositions and methods for a low cost, tunable, macroporous, alginate scaffold that transduces T cells with vectors under static condition.
Engineered Three-Dimensional Skin Tissues, Arrays Thereof, and Methods of Making the Same
Disclosed are bioprinted, three-dimensional, biological skin tissues comprising: a dermal layer comprising dermal fibroblasts; and an epidermal layer comprising keratinocytes, the epidermal layer in contact with the dermal layer to form the three-dimensional, engineered, biological skin tissue. Also disclosed are arrays of engineered skin tissues and methods of making engineered skin tissues.
SCAFFOLD, METHOD FOR PRODUCING SCAFFOLD, CELL CULTURE CONSTRUCT, METHOD FOR CULTURING CELL
A scaffold for culturing a cell comprises: a hydrogel; and a plasma-derived or platelet-derived component or a fibrin-containing material adhered to the hydrogel.
CELL HARVEST METHOD
The invention generally relates to cells and compositions comprising same for use in cell therapy, to methods of obtaining same, and to use of same in cell therapy. In one aspect, the invention provides a method for forming a cell composition from a tissue sample, the method comprising: providing a tissue sample comprising cells; contacting the sample with a polymer in binding conditions, said binding conditions being conditions that enable binding of cells in the sample to the polymer, so that said cells are bound to the polymer; culturing the cells bound to the polymer under conditions and for a time that allows the cell number to increase; providing conditions to induce a phase change of the polymer; thereby forming a cell composition from a tissue sample.
METHOD FOR STABLY AMPLIFYING PLURIPOTENT STEM CELL
A method for stably amplifying a pluripotent stem cell comprises the following steps: (a) a cell implantation step: implanting pluripotent stem cells directly into a porous scaffold such that the porous scaffold contains 1×10.sup.4 or more of the pluripotent stem cells; and (b) a cell amplification step: immersing the porous scaffold in a specific culture medium which is xeno-free (XF) and performing amplification culture at an ambient temperature of 35.5-39.5° C. and a CO.sub.2 concentration of 5% to obtain the amplified pluripotent stem cells, wherein the amplified pluripotent stem cells aggregate to present an embryoid body state. The amplification method of the present disclosure can easily obtain an excellent effect of increasing an amplification multiple of the pluripotent stem cells to about 3 times or more.
SYSTEM, DEVICE, AND METHOD FOR SINGLE-CELL ENCAPSULATION AND CULTURE
The disclosure relates generally to a system, device, and method for cell culturing. In certain embodiments, the system, device, and method may be used to encapsulate single cells in embryo-like, core-shell microcapsules. In some embodiments, microfluidic devices may be utilized to fabricate core-shell hydrogel microcapsules, which may be used to encapsulate individual cells. In some embodiments, the disclosed system and method are utilized to encapsulate cancer stem cells. The disclosed system, device, and method can be used to isolate and culture CSCs, to facilitate the understanding of cancer biology and etiology, and to advance the development of effective CSC-targeted cancer therapies.
Device and methods for printing biological tissues and organs
Techniques for printing living tissues and organs are provided. An example apparatus includes a printing platform, bioink printing module with at least one nozzle designed for bioink dosing, a gel-forming composition printing module containing a UV-module, and a nozzle for dosing gel-forming composition that starts polymerizing via UV radiation. A module is provided for relatively displacing the nozzles and/or the platform, in which the bioink printing module is separated from the gel-forming-composition printing module to prevent UV radiation from reaching the bioink printing module. The radiation is directed predominantly parallel to the printing platform to prevent UV radiation from reaching the biological tissues and/or organs being printed. A multi-functional device capable of combining various printing modes, providing a method of high-resolution printing of living tissues and organs based on UV-induced hydrogel polymerization, and a method of cell protection from UV radiation during the printing process, can be realized.
Method of selectively differentiating undifferentiated macrophage into M1 macrophage
Provided is a method for the selective differentiation into M1 macrophages under a pressurized environment, and more particularly, a method for the selective differentiation of undifferentiated macrophages into M1 macrophages, the method including incubating the undifferentiated macrophages in an incubator under the pressurized environment. In addition, provided is a method for producing osteoclasts, the method including: incubating undifferentiated macrophages in an incubator under a pressurized environment to differentiate into M1 macrophages; and differentiating the differentiated M1 macrophages into osteoclasts.